 | • レポートコード：QYR9N7609 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、重症筋無力症のグローバル市場について調査・分析したレポートで、種類別（薬物治療、迅速な免疫療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・重症筋無力症の世界市場規模 ・主要企業別市場シェア ・重症筋無力症の世界市場規模：種類別（薬物治療、迅速な免疫療法） ・重症筋無力症の世界市場規模：用途別（病院、診療所、その他） ・重症筋無力症のアメリカ市場規模（種類別、用途別） ・重症筋無力症のヨーロッパ市場規模（種類別、用途別） ・重症筋無力症の中国市場規模（種類別、用途別） ・重症筋無力症の日本市場規模（種類別、用途別） ・重症筋無力症の東南アジア市場規模（種類別、用途別） ・重症筋無力症のインド市場規模（種類別、用途別） ・重症筋無力症の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・重症筋無力症の世界市場予測（2019年-2025年） ・重症筋無力症の地域別市場予測（2019年-2025年） ... |
In 2018, the global Myasthenia Gravis market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Myasthenia Gravis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Myasthenia Gravis development in United States, Europe and China.
The key players covered in this study
Shire
F. Hoffmann-La Roche
CSL Behring
Grifols
Alexion Pharmaceutical
Avadel Pharmaceuticals
Baxter International
Novartis
Valeant Pharmaceuticals International
Takeda Pharmaceutical Company
Market segment by Type, the product can be split into
Drug Treatment
Rapid Immunotherapies
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Myasthenia Gravis status, future forecast, growth opportunity, key market and key players.
To present the Myasthenia Gravis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Myasthenia Gravis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Myasthenia Gravis Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Treatment
1.4.3 Rapid Immunotherapies
1.5 Market by Application
1.5.1 Global Myasthenia Gravis Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Myasthenia Gravis Market Size
2.2 Myasthenia Gravis Growth Trends by Regions
2.2.1 Myasthenia Gravis Market Size by Regions (2014-2025)
2.2.2 Myasthenia Gravis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Myasthenia Gravis Market Size by Manufacturers
3.1.1 Global Myasthenia Gravis Revenue by Manufacturers (2014-2019)
3.1.2 Global Myasthenia Gravis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Myasthenia Gravis Market Concentration Ratio (CR5 and HHI)
3.2 Myasthenia Gravis Key Players Head office and Area Served
3.3 Key Players Myasthenia Gravis Product/Solution/Service
3.4 Date of Enter into Myasthenia Gravis Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Myasthenia Gravis Market Size by Type (2014-2019)
4.2 Global Myasthenia Gravis Market Size by Application (2014-2019)
5 United States
5.1 United States Myasthenia Gravis Market Size (2014-2019)
5.2 Myasthenia Gravis Key Players in United States
5.3 United States Myasthenia Gravis Market Size by Type
5.4 United States Myasthenia Gravis Market Size by Application
6 Europe
6.1 Europe Myasthenia Gravis Market Size (2014-2019)
6.2 Myasthenia Gravis Key Players in Europe
6.3 Europe Myasthenia Gravis Market Size by Type
6.4 Europe Myasthenia Gravis Market Size by Application
7 China
7.1 China Myasthenia Gravis Market Size (2014-2019)
7.2 Myasthenia Gravis Key Players in China
7.3 China Myasthenia Gravis Market Size by Type
7.4 China Myasthenia Gravis Market Size by Application
8 Japan
8.1 Japan Myasthenia Gravis Market Size (2014-2019)
8.2 Myasthenia Gravis Key Players in Japan
8.3 Japan Myasthenia Gravis Market Size by Type
8.4 Japan Myasthenia Gravis Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Myasthenia Gravis Market Size (2014-2019)
9.2 Myasthenia Gravis Key Players in Southeast Asia
9.3 Southeast Asia Myasthenia Gravis Market Size by Type
9.4 Southeast Asia Myasthenia Gravis Market Size by Application
10 India
10.1 India Myasthenia Gravis Market Size (2014-2019)
10.2 Myasthenia Gravis Key Players in India
10.3 India Myasthenia Gravis Market Size by Type
10.4 India Myasthenia Gravis Market Size by Application
11 Central & South America
11.1 Central & South America Myasthenia Gravis Market Size (2014-2019)
11.2 Myasthenia Gravis Key Players in Central & South America
11.3 Central & South America Myasthenia Gravis Market Size by Type
11.4 Central & South America Myasthenia Gravis Market Size by Application
12 International Players Profiles
12.1 Shire
12.1.1 Shire Company Details
12.1.2 Company Description and Business Overview
12.1.3 Myasthenia Gravis Introduction
12.1.4 Shire Revenue in Myasthenia Gravis Business (2014-2019)
12.1.5 Shire Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Myasthenia Gravis Introduction
12.2.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 CSL Behring
12.3.1 CSL Behring Company Details
12.3.2 Company Description and Business Overview
12.3.3 Myasthenia Gravis Introduction
12.3.4 CSL Behring Revenue in Myasthenia Gravis Business (2014-2019)
12.3.5 CSL Behring Recent Development
12.4 Grifols
12.4.1 Grifols Company Details
12.4.2 Company Description and Business Overview
12.4.3 Myasthenia Gravis Introduction
12.4.4 Grifols Revenue in Myasthenia Gravis Business (2014-2019)
12.4.5 Grifols Recent Development
12.5 Alexion Pharmaceutical
12.5.1 Alexion Pharmaceutical Company Details
12.5.2 Company Description and Business Overview
12.5.3 Myasthenia Gravis Introduction
12.5.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2014-2019)
12.5.5 Alexion Pharmaceutical Recent Development
12.6 Avadel Pharmaceuticals
12.6.1 Avadel Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Myasthenia Gravis Introduction
12.6.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2014-2019)
12.6.5 Avadel Pharmaceuticals Recent Development
12.7 Baxter International
12.7.1 Baxter International Company Details
12.7.2 Company Description and Business Overview
12.7.3 Myasthenia Gravis Introduction
12.7.4 Baxter International Revenue in Myasthenia Gravis Business (2014-2019)
12.7.5 Baxter International Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Myasthenia Gravis Introduction
12.8.4 Novartis Revenue in Myasthenia Gravis Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Valeant Pharmaceuticals International
12.9.1 Valeant Pharmaceuticals International Company Details
12.9.2 Company Description and Business Overview
12.9.3 Myasthenia Gravis Introduction
12.9.4 Valeant Pharmaceuticals International Revenue in Myasthenia Gravis Business (2014-2019)
12.9.5 Valeant Pharmaceuticals International Recent Development
12.10 Takeda Pharmaceutical Company
12.10.1 Takeda Pharmaceutical Company Company Details
12.10.2 Company Description and Business Overview
12.10.3 Myasthenia Gravis Introduction
12.10.4 Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2014-2019)
12.10.5 Takeda Pharmaceutical Company Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Myasthenia Gravis Key Market Segments
Table Key Players Myasthenia Gravis Covered
Table Global Myasthenia Gravis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Myasthenia Gravis Market Size Market Share by Type 2014-2025
Figure Drug Treatment Figures
Table Key Players of Drug Treatment
Figure Rapid Immunotherapies Figures
Table Key Players of Rapid Immunotherapies
Table Global Myasthenia Gravis Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Myasthenia Gravis Report Years Considered
Table Global Myasthenia Gravis Market Size 2014-2025 (Million US$)
Figure Global Myasthenia Gravis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Myasthenia Gravis Market Size by Regions 2014-2025 (Million US$)
Table Global Myasthenia Gravis Market Size by Regions 2014-2019 (Million US$)
Table Global Myasthenia Gravis Market Share by Regions 2014-2019
Figure Global Myasthenia Gravis Market Share by Regions 2014-2019
Figure Global Myasthenia Gravis Market Share by Regions 2019
Table Market Top Trends
Table Global Myasthenia Gravis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Myasthenia Gravis Market Share by Manufacturers (2014-2019)
Figure Global Myasthenia Gravis Market Share by Manufacturers in 2018
Table Global Myasthenia Gravis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Myasthenia Gravis Product/Solution/Service
Table Date of Enter into Myasthenia Gravis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Myasthenia Gravis Market Size by Type (2014-2019) (Million US$)
Table Global Myasthenia Gravis Market Size Share by Type (2014-2019)
Figure Global Myasthenia Gravis Market Size Market Share by Type (2014-2019)
Table Global Myasthenia Gravis Market Size by Application (2014-2019) (Million US$)
Table Global Myasthenia Gravis Market Size Share by Application (2014-2019)
Figure Global Myasthenia Gravis Market Size Market Share by Application (2014-2019)
Figure Global Myasthenia Gravis Revenue Market Share by Application in 2018
Figure United States Myasthenia Gravis Market Size 2014-2019 (Million US$)
Table United States Key Players Myasthenia Gravis Revenue (2018-2019) (Million US$)
Table United States Key Players Myasthenia Gravis Market Share (2018-2019)
Table United States Myasthenia Gravis Market Size by Type (2014-2019) (Million US$)
Table United States Myasthenia Gravis Market Share by Type (2014-2019)
Table United States Myasthenia Gravis Market Size by Application (2014-2019) (Million US$)
Table United States Myasthenia Gravis Market Share by Application (2014-2019)
Figure Europe Myasthenia Gravis Market Size 2014-2019 (Million US$)
Table Europe Key Players Myasthenia Gravis Revenue (2018-2019) (Million US$)
Table Europe Key Players Myasthenia Gravis Market Share (2018-2019)
Table Europe Myasthenia Gravis Market Size by Type (2014-2019) (Million US$)
Table Europe Myasthenia Gravis Market Share by Type (2014-2019)
Table Europe Myasthenia Gravis Market Size by Application (2014-2019) (Million US$)
Table Europe Myasthenia Gravis Market Share by Application (2014-2019)
Figure China Myasthenia Gravis Market Size 2014-2019 (Million US$)
Table China Key Players Myasthenia Gravis Revenue (2018-2019) (Million US$)
Table China Key Players Myasthenia Gravis Market Share (2018-2019)
Table China Myasthenia Gravis Market Size by Type (2014-20189) (Million US$)
Table China Myasthenia Gravis Market Share by Type (2014-2019)
Table China Myasthenia Gravis Market Size by Application (2014-2019) (Million US$)
Table China Myasthenia Gravis Market Share by Application (2014-2019)
Figure Japan Myasthenia Gravis Market Size 2014-2019 (Million US$)
Table Japan Key Players Myasthenia Gravis Revenue (2018-2019) (Million US$)
Table Japan Key Players Myasthenia Gravis Market Share (2018-2019)
Table Japan Myasthenia Gravis Market Size by Type (2014-2019) (Million US$)
Table Japan Myasthenia Gravis Market Share by Type (2014-2019)
Table Japan Myasthenia Gravis Market Size by Application (2014-2019) (Million US$)
Table Japan Myasthenia Gravis Market Share by Application (2014-2019)
Figure Southeast Asia Myasthenia Gravis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Myasthenia Gravis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Myasthenia Gravis Market Share (2018-2019)
Table Southeast Asia Myasthenia Gravis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Myasthenia Gravis Market Share by Type (2014-2019)
Table Southeast Asia Myasthenia Gravis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Myasthenia Gravis Market Share by Application (2014-2019)
Figure India Myasthenia Gravis Market Size 2014-2019 (Million US$)
Table India Key Players Myasthenia Gravis Revenue (2018-2019) (Million US$)
Table India Key Players Myasthenia Gravis Market Share (2018-2019)
Table India Myasthenia Gravis Market Size by Type (2014-2019) (Million US$)
Table India Myasthenia Gravis Market Share by Type (2014-2019)
Table India Myasthenia Gravis Market Size by Application (2014-2019) (Million US$)
Table India Myasthenia Gravis Market Share by Application (2014-2019)
Figure Central & South America Myasthenia Gravis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Myasthenia Gravis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Myasthenia Gravis Market Share (2018-2019)
Table Central & South America Myasthenia Gravis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Myasthenia Gravis Market Share by Type (2014-2019)
Table Central & South America Myasthenia Gravis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Myasthenia Gravis Market Share by Application (2014-2019)
Table Shire Company Details
Table Shire Revenue in Myasthenia Gravis Business (2014-2019) (Million US$)
Figure Shire Revenue Growth Rate in Myasthenia Gravis Business (2014-2019)
Table Shire Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table CSL Behring Company Details
Table CSL Behring Revenue in Myasthenia Gravis Business (2014-2019)(Million US$)
Figure CSL Behring Revenue Growth Rate in Myasthenia Gravis Business (2014-2019)
Table CSL Behring Recent Development
Table Grifols Company Details
Table Grifols Revenue in Myasthenia Gravis Business (2014-2019)(Million US$)
Figure Grifols Revenue Growth Rate in Myasthenia Gravis Business (2014-2019)
Table Grifols Recent Development
Table Alexion Pharmaceutical Company Details
Table Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2014-2019)(Million US$)
Figure Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis Business (2014-2019)
Table Alexion Pharmaceutical Recent Development
Table Avadel Pharmaceuticals Company Details
Table Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2014-2019)(Million US$)
Figure Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Business (2014-2019)
Table Avadel Pharmaceuticals Recent Development
Table Baxter International Company Details
Table Baxter International Revenue in Myasthenia Gravis Business (2014-2019)(Million US$)
Figure Baxter International Revenue Growth Rate in Myasthenia Gravis Business (2014-2019)
Table Baxter International Recent Development
Table Novartis Company Details
Table Novartis Revenue in Myasthenia Gravis Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Myasthenia Gravis Business (2014-2019)
Table Novartis Recent Development
Table Valeant Pharmaceuticals International Company Details
Table Valeant Pharmaceuticals International Revenue in Myasthenia Gravis Business (2014-2019)(Million US$)
Figure Valeant Pharmaceuticals International Revenue Growth Rate in Myasthenia Gravis Business (2014-2019)
Table Valeant Pharmaceuticals International Recent Development
Table Takeda Pharmaceutical Company Company Details
Table Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Company Revenue Growth Rate in Myasthenia Gravis Business (2014-2019)
Table Takeda Pharmaceutical Company Recent Development
Table Global Myasthenia Gravis Market Size by Regions (Million US$) 2019-2025
Figure Global Myasthenia Gravis Market Size Share by Regions (2019-2025)
Figure Global Myasthenia Gravis Market Size Share by Regions in 2025
Figure United States Myasthenia Gravis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Myasthenia Gravis Market Size Forecast (2019-2025)(Million USD)
Figure China Myasthenia Gravis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Myasthenia Gravis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Myasthenia Gravis Market Size Forecast (2019-2025)(Million USD)
Figure India Myasthenia Gravis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Myasthenia Gravis Market Size Forecast (2019-2025)(Million USD)
Table Global Myasthenia Gravis Market Size by Product (2019-2025) (Million US$)
Figure Global Myasthenia Gravis Market Size by Product (2019-2025)
Figure Global Myasthenia Gravis Market Size by Product in 2025
Table Global Myasthenia Gravis Market Size by Application (2019-2025) (Million US$)
Figure Global Myasthenia Gravis Market Size by Application (2019-2025)
Figure Global Myasthenia Gravis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の重症筋無力症の治療市場：市場規模・現状・予測 Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles, which are responsible for breathing and moving parts of the body, including the arms and legs.In 2018, the global Myasthenia Gravis Therapies market size was xx million US$ and it is expecte…- 世界の食物アレルギー免疫療法市場：市場規模・現状・予測 Food allergy is an immune system reaction that occurs soon after eating a certain food.In 2018, the global Food Allergy Immunotherapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global…
- 世界の薬物中毒治療市場：市場規模・現状・予測 Drug addiction is a complex neurobiological disease that requires integrated treatment of the mind, body, and spirit. It is considered a brain disease because drugs change the brain — they change its structure and how it works. Without treatment, these brain changes can be long-lasting. Addiction is…
- 世界の薬物乱用治療市場：市場規模・現状・予測 Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for t…
- 世界の高速試薬ディスペンサー市場：市場規模・現状・予測 Linearity on reagent dispensing is very useful for the alteration since it allows cassette producers forecast reagent volumes by altering dispensing factors.The rapid reagent dispenser market is expected to grow rapidly over the forecast period owing to development in technology and demand for quick…